Prostate Cancer (cont.)
IN THIS ARTICLE
Chemotherapy is the also used against prostate cancer.
Newer chemotherapy medicines, such as docetaxel (Taxotere), have shown some promise in prolonging the survival of some patients with extensive prostate cancer. They may also decrease the pain related to widespread cancer. However, this comes at the cost of significant side effects that may impact quality of life.
Symptom palliation: The primary approach to the management of symptoms in patients with advanced prostate cancer is systemic therapy with hormomal then chemotherapy. Today immunotherapy and radioactive isotope treatments may be used. Radiation to painful bone lesions may be used. Throughout all of this, optimal pain medicine use and other therapies for cancer-related symptoms should be administered. For patients with castrate-resistant prostate cancer, palliative therapy may be indicated to treat symptomatic bone metastases or symptoms arising from progressive disease.
Prostate Cancer Follow-up
Follow-up care is especially important for patients who opted for a more conservative approach (such as watchful waiting) to treat prostate cancer. It is imperative that a man see his urologist for digital rectal exams, PSA level tests, and other tests as recommended to follow the progression of cancer growth.
For men who have undergone radical prostatectomy, radiation therapy, or both, follow-up care is important to prevent cancer recurrence.
Medically Reviewed by a Doctor on 12/16/2014
Must Read Articles Related to Prostate Cancer
Patient Comments & Reviews
The eMedicineHealth doctors ask about Prostate Cancer:
Prostate Cancer - Symptoms
The symptoms of prostate cancer can vary greatly from patient to patient. What were your symptoms at the onset of your disease?
Prostate Cancer - Diagnosis
How was your prostate cancer diagnosed?
Prostate Cancer - Treatment
What was the treatment for your prostate cancer?
Prostate Cancer - Prognosis
What is your prostate cancer prognosis?
Prostate Cancer - Surgery
Did you opt for surgery for your prostate cancer? Why or why not?
Read What Your Physician is Reading on Medscape
Prostate cancer is the most common noncutaneous cancer among males.